Redmile Group, LLC - Director, 10%+ Owner at IGM Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
IGMS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Redmile Group, LLC since 7/7/2023

Holdings reported by Redmile Group, LLC for IGM Biosciences, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Non-Voting Common Stock 7,199,325 $47.5 M $6.60 Feb 28, 2024 Indirect Common Stock
Common Stock 3,080,066 $23.3 M $7.58 Jun 28, 2024 Indirect
Stock Option (Right to Buy) 29,400 Mar 12, 2024 Indirect Common Stock

Transactions reported by Redmile Group, LLC for IGM Biosciences, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership